RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma. (Q41450925)
Jump to navigation
Jump to search
scientific article published on 17 August 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma. |
scientific article published on 17 August 2017 |
Statements
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma (English)
Kanako Shimizu
Kerstin F Gerer
Gerold Schuler
Stefanie Hoyer
Shin-Ichiro Fujii
Ugur Uslu
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference